Effect of hypomethylating agents on prognosis in acute myeloid leukemia patients treated with HAG priming: a systematic review and meta-analysis

Objectives A combination of hypomethylation agents (HMA) and the HAG regimen (homoharringtonine, cytarabine, G-CSF) shows promise as a treatment for Acute Myeloid Leukemia (AML). Nevertheless, the clinical efficacy of this combined therapy in contrast to the HAG regimen alone remains uncertain.Metho...

Full description

Bibliographic Details
Published in:Hematology
Main Authors: Jun Li, Shuying Fu, Chunmei Ye
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Subjects:
Acute myeloid leukemia
hypomethylation agents
azacitidine
decitabine
HAG regimen
meta-analysis
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2024.2439054

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2024.2439054

Similar Items